Atrophic Gastritis in the Arctic

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 9, 2015, Pages 1601-1603

  Genta, Robert M ^a,b   Rugge, Massimo ^c  

^a MIRACA LIFE SCIENCES   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); PEPSINOGEN I;

ARCTIC; ATROPHIC GASTRITIS; AUTOIMMUNE DISEASE; CANCER RISK; DISEASE ASSOCIATION; EDITORIAL; ENZYME BLOOD LEVEL; HELICOBACTER INFECTION; HUMAN; INFECTION RISK; PREVALENCE; RACE DIFFERENCE; STOMACH CANCER; SWEDEN; FEMALE; GASTRITIS, ATROPHIC; MALE;

FEMALE; GASTRITIS, ATROPHIC; HUMANS; MALE;

EID: 84939568887     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.05.016     Document Type: Editorial

References (26)

1. Fenwick S. On atrophy of the stomach. Lancet 1870, ii:78.
2. Rugge M., Correa P., Dixon M.F., et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002, 16:1249-1259.
3. Rugge M., Genta R.M. Staging and grading of chronic gastritis. Hum Pathol 2005, 36:228-233.
4. Rugge M., Correa P., Di Mario F., et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis 2008, 40:650-658.
5. Song H., Held M., Sandin S., et al. Increase in the prevalence of atrophic gastritis among adults age 35 to 44 years old in northern sweden between 1990 and 2009. Clin Gastroenterol Hepatol 2015, 13:1592-1600.
6. Oksanen A., Sipponen P., Karttunen R., et al. Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy. Gut 2000, 46:460-463.
7. Miki K., Ichinose M., Ishikawa K.B., et al. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer. Jpn J Cancer Res 1993, 84:1086-1090.
8. Agreus L., Kuipers E.J., Kupcinskas L., et al. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol 2012, 47:136-147.
9. Negrini R., Lisato L., Zanella I., et al. Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology 1991, 101:437-445.
10. Appelmelk B.J., Simoons-Smit I., Negrini R., et al. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect Immun 1996, 64:2031-2040.
11. Faller G., Winter M., Steininger H., et al. Decrease of antigastric autoantibodies in Helicobacter pylori gastritis after cure of infection. Pathol Res Pract 1999, 195:243-246.
12. Claeys D., Faller G., Appelmelk B.J., et al. The gastric H+, K+-ATPase is a major autoantigen in chronic H. pylori gastritis with body mucosa atrophy. Gastroenterology 1998, 115:340-347.
13. Negrini R., Savio A., Poiesi C., et al. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 1996, 111:655-665.
14. Faller G., Steininger H., Kranzlein J., et al. Antigastric autoantibodies in Helicobacter pylori infection: implications of histological and clinical parameters of gastritis. Gut 1997, 41:619-623.
15. Muller H., Rappel S., Wundisch T., et al. Healing of active, non-atrophic autoimmune gastritis by H. pylori eradication. Digestion 2001, 64:30-39.
16. Thjodleifsson B., Asbjörnsdottir H., Sigurjonsdottir R.B., et al. Seroprevalence of Helicobacter pylori and cagA antibodies in Iceland, Estonia and Sweden. Scand J Infect Dis 2007, 39:683-689.
17. Kotyrlo E. Labour market outcomes of migrant women in Västerbotten and Norrebotten. The Arctic Yearbook 2104. 2014. http://www.arcticyearbook.com.
18. Holcombe C. Helicobacter pylori: the African enigma. Gut 1992, 33:429-431.
19. Misra V., Pandey R., Misra S.P., et al. Helicobacter pylori and gastric cancer: Indian enigma. World J Gastroenterol 2014, 20:1503-1509.
20. Peltonen M., Huhtasaari F., Stegmayr B., et al. Secular trends in social patterning of cardiovascular risk factor levels in Sweden: the Northern Sweden MONICA Study 1986-1994-multinational monitoring of trends and determinants in cardiovascular disease. J Intern Med 1998, 244:1-9.
21. Kutsuma A., Oshida H., Suwa K., et al. A possible association of low pepsinogen I and pepsinogen I/II with low and high body weight in Japanese men. Clin Biochem 2014, 47:126-128.
22. Ludvigsson J.F., Montgomery S.M., Ekbom A., et al. Small-intestinal histopathology and mortality risk in celiac disease. JAMA 2009, 302:1171-1178.
23. Ludvigsson J.F., Brandt L., Montgomery S.M., et al. Validation study of villous atrophy and small intestinal inflammation in Swedish biopsy registers. BMC Gastroenterol 2009, 9:19.
24. Lebwohl B., Murray J.A., Rubio-Tapia A., et al. Predictors of persistent villous atrophy in coeliac disease: a population-based study. Aliment Pharmacol Ther 2014, 39:488-495.
25. Rugge M., Fassan M., Pizzi M., et al. Autoimmune gastritis: histology phenotype and OLGA staging. Aliment Pharmacol Ther 2012, 35:1460-1466.
26. Genta R.M., Allen R., Rugge M. Ethnic distribution of atrophic autoimmune gastritis in the United States. Gastrointest Endosc 2014, 79(Suppl 5):AB148.